Navigation Links
IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
Date:11/7/2013

MOUNTAIN VIEW, Calif., Nov. 7, 2013 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that, effective immediately, it has promoted sales and marketing executive Timothy D. Buckley to Vice President of Marketing and North American Sales. Buckley had previously taken over interim responsibility for domestic sales earlier this year, and will continue to report directly to James H. Mackaness, Chief Financial Officer and Chief Operating Officer.

Buckley, 38, has more than 16 years of experience in the medical device industry, including roles in sales, marketing and product development within the ophthalmology industry, for industry leaders such as Carl Zeiss Meditec and transformative start-ups such as Transcend Medical. He is the former CEO and co-founder of Alamo, CA-based Ocunetics, and joined IRIDEX in September 2011 when Ocunetics licensed its technologies to IRIDEX.

"Tim's efforts have been very impressive and I am confident that under his leadership the marketing and sales teams will continue to build on the momentum and the successes they have shown during the first nine months of 2013," Mackaness said.  "We have enjoyed an excellent year at IRIDEX, and Tim has played an important role in our efforts."

Buckley will be responsible for worldwide marketing and all North American sales, including direct and independent sales forces in the U.S. and the Company's distribution effort in Canada.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our c
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. IRIDEX Introduces Non-Invasive MicroPulseâ„¢ Therapy for Glaucoma
2. IRIDEX Reports 2012 First Quarter Results
3. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
4. IRIDEX Reports 2012 Second Quarter Results
5. IRIDEX Appoints Chairman William M. Moore as Interim President & CEO
6. IRIDEX Announces Third Quarter 2012 Conference Call and Release Date
7. IRIDEX Reports 2012 Third Quarter Results
8. IRIDEX Announces Tender Offer to Purchase up to 487,500 Shares of its Common Stock
9. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
10. IRIDEX Announces FDA 510(k) and CE Clearance of New Laser Delivery System for Fast, Non-invasive Treatment of Serious Retinal Diseases
11. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... leading,developer of medical simulation systems, today announced an agreement ... and related,products. , Johnson & ... and,is one of the subsidiaries of Johnson & Johnson. ... will have exclusive rights to distribute,Simbionix,s line of advanced ...
... Newly Diagnosed Patients Receive a Drug Within One Year ... from Decision ResourcesWALTHAM, Mass., April 15 /PRNewswire/ ... leading research and advisory firms focusing on pharmaceutical and ... than 30 percent of their use of emerging oral ...
Cached Medicine Technology:Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 3
(Date:7/9/2014)... users in Russia might contribute to HIV transmission ... by researchers from Boston University Schools of Medicine ... Pavlov State University, sought to discover the effect ... a cohort of HIV-positive people with lifetime of ... by police were more likely to share needlesincreasing ...
(Date:7/9/2014)... July 9, 2014 There has been a sharp ... Southwestern Medical Center using MyChart, the online, interactive service ... communicate with their healthcare providers, schedule appointments, and renew ... patients actively using MyChart each year increased ... increased more than 10-fold, according to a study by ...
(Date:7/9/2014)... flatulence and have a reputation for being highly toxic, but ... now being being found to offer potential health benefits in ... and dementia. A new compound (AP39), designed and made at ... therapies, by targeting delivery of very small amounts of the ... , Scientists in Exeter have already found that the compound ...
(Date:7/9/2014)... prescription labels handed out by pharmacists may be ... medication, according to new research by the University ... the Blind)., The study, published recently in the ... on prescription medications dispensed by pharmacies do not ... By simply following recommended guidelines for font size, ...
(Date:7/9/2014)... has risen dramatically in Western societies. One frequently cited ... and have fewer infections than previous generations, thereby delaying ... researchers at Sahlgrenska Academy, University of Gothenburg, monitored children ... the immune system in relation to allergic disease. All ... Vstra Gtaland Region, half of them on farms that ...
Breaking Medicine News(10 mins):Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... 2008 -- Women born after 1944 began drinking alcohol at ... put them at greater risk for alcoholism, according to researchers ... On average, women born before 1944 began drinking at age ... 17, and they had a 50 to 80 percent greater ...
... and ... Launch in Spanish, CHICAGO and ... in health education, and Merck & Co.,Inc., a global research-driven pharmaceutical ... multi-year relationship,to transform how healthcare professionals engage patients in learning about,diabetes ...
... June 5 Nuvelo, Inc.,(Nasdaq: NUVO ) ... the,company,s Wnt Therapeutics program showing that the R-spondin ... pathway that is critical for,cell growth and differentiation ... the activity of Wnt proteins, and,modulated the Wnt ...
... FALLS CHURCH, Va., June 5 CSC (NYSE: ... LLC (DVC), a CSC company, has been,notified by ... funding for,advanced development of plague vaccine will be ... Project Manager Chemical, Biological and,Medical Systems, Joint Vaccine ...
... of alcohol a week can trim that risk by 50%, ... who drink alcohol regularly may cut their risk of developing ... been shown to reduce the risk of cardiovascular disease, and ... risk of rheumatoid arthritis by up to 50 percent. This ...
... LEAN CUISINE(R) are Nutritious and Delicious, SOLON, Ohio, ... know they,re good for us and want to reap ... how to incorporate them into,convenient and tasty meals. A ... benefits of the Omega-3 fatty acids DHA and,EPA. These ...
Cached Medicine News:Health News:Initiating drinking at younger age heightens women's risk for alcohol dependence 2Health News:Initiating drinking at younger age heightens women's risk for alcohol dependence 3Health News:Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S. 2Health News:Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S. 3Health News:Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U.S. 4Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 2Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 3Health News:CSC's DynPort Vaccine Company to Continue Plague Vaccine Development 2Health News:CSC's DynPort Vaccine Company to Continue Plague Vaccine Development 3Health News:Drinking Cuts Rheumatoid Arthritis Risk 2Health News:Drinking Cuts Rheumatoid Arthritis Risk 3Health News:Now You Can Have Your Fish and Enjoy It Too... 2Health News:Now You Can Have Your Fish and Enjoy It Too... 3
Toxoplasma IgM II ELISA....
HSV 1 & HSV 2 DFA Test....
Herpes Simplex Virus 2 IgG ELISA....
Herpes Simplex Virus 1 IgG ELISA....
Medicine Products: